Dr. Stewart joined the faculty of the department of pharmacy practice in 2007. Prior to his appointment of Assistant Professor at ETSU he served as an Assistant Clinical Professor at the Auburn University Harrison School of Pharmacy. Dr. Stewart was promoted to Associate Professor of Pharmacy Practice in 2012 and Professor in 2018. He also serves as the Residency Program Director for the college’s PGY2 Internal Medicine Pharmacy Residency Program and Post-graduate Training Coordinator for the Department of Pharmacy Practice. Over his tenure at the BGCOP he has taught various courses including Pharmacotherapy, Advanced Clinical Practice Skills, and electives in Anticoagulation and Professional Development. His clinical interests include anticoagulation and cardiology pharmacotherapy. His current research focuses on anticoagulant and cardiovascular pharmacotherapy and the use of active learning in pharmacy education. Dr. Stewart is an internal medicine practitioner and maintains an active clinical practice with the ETSU Department of Family Medicine at Johnson City Medical Center where he engages pharmacy students and residents as well as medical students and residents in various teaching capacities.
Education, Degree, & Post Graduate Training:
Doctor of Pharmacy – Campbell University 2003
Pharmacy Practice Residency – Wake Forest University Baptist Medical Center 2004
After completing residency worked as clinical pharmacist at WFUBMC until joining faculty of Auburn University Harrison School of Pharmacy in 2005. Joined inaugural faculty of ETSU in 2007.
Anticoagulation and Cardiovascular Pharmacotherapy
Integrated Series, Advanced Clinical Practice Skills, Anticoagulation Elective
Anticoagulation, Cardiovascular Medicine, and Active Learning in Pharmacy Education
Lindquist DE, Stewart DW, Brewster A, Waldroup C, Odle BL, Burchette JE, El-Bazouni
H. Clin Appl Thromb Hemost. 2018 Jan 1:1076029618772337. DOI: 10.1177/1076029618772337.
Ricket AL, Stewart DW, Wood RC, Cornett L, Odle B, Cluck D, Freshour J, El-Bazouni H. Comparison of post-operative bleeding in THA and TKA patients receiving rivaroxaban or enoxaparin. Ann Pharmacother 2016; DOI: 10.1177/1060028015626435.
Wood RC, Stewart DW, Slusher L, El-Bazouni H, Cluck D, Freshour J, and Odle B. Retrospective evaluation of postoperative bleeding events in patients receiving rivaroxaban after undergoing total hip and total knee arthroplasty: comparison with clinical trial data. Pharmacother 2015;35(7):663-9.
Stewart DW and Freshour JE. Aspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence. Ann Pharmacother 2013;47(1):63-74.
Significant Regional, State, or National Service:
Member and past chair of the American College of Clinical Pharmacy Member Relations Committee, Past Member and Chair of Southeastern Residency Conference Steering Committee
Member of AACP, ACCP, and ASHP
Personal motto or favorite quote:
The only thing necessary for the triumph of evil is for good men to do nothing. - Edmund Burke